PMID- 34699842
OWN - NLM
STAT- MEDLINE
DCOM- 20220420
LR  - 20220531
IS  - 1520-6017 (Electronic)
IS  - 0022-3549 (Linking)
VI  - 111
IP  - 5
DP  - 2022 May
TI  - A Tribute to Professor Saranjit Singh - A Critical Thinker, Innovator, Mentor, 
      and Educator.
PG  - 1224-1231
LID - S0022-3549(21)00566-9 [pii]
LID - 10.1016/j.xphs.2021.10.024 [doi]
AB  - This commentary presents contributions and accomplishments of Professor Saranjit 
      Singh, National Institute of Pharmaceutical Education and Research (NIPER), SAS 
      Nagar, India, to pharmaceutical research and education. Prof. Singh completed his 
      successful tenure in October 2021. Over his 40+ years of illustrious academic 
      career, he trained 147 Masters and 15 PhD students in the fields of drug 
      stability testing, degradation chemistry, impurity and metabolite 
      characterization, and advanced analytical technologies. He has published  approximately 250 
      research articles, reviews, editorials, patent, book, and book chapters, and 
      received numerous awards, including the Professor M.L. Khorana Memorial Lecture 
      Award from the Indian Pharmaceutical Association (IPA) and the Outstanding 
      Analyst and Eminent Analyst awards from the Indian Drug Manufacturers' 
      Association (IDMA). This commentary highlights Prof. Singh's inspiring personal 
      and renowned professional journey, including early life, education, career, 
      accomplishments, as well as his services to academia, industry, and regulatory. 
      By sharing the contributions and accomplishments of Prof. Singh, we strongly 
      believe that his story will inspire the next generation of scientists to continue 
      his legacy to advance the field.
CI  - Copyright (c) 2021 American Pharmacists Association. Published by Elsevier Inc. All 
      rights reserved.
FAU - Ladumor, Mayur K
AU  - Ladumor MK
AD  - Department of Pharmaceutics, University of Washington, Seattle, WA.
FAU - Paudel, Amrit
AU  - Paudel A
AD  - Institute of Process and Particle Engineering, Graz University of Technology, 
      Inffeldgasse 13, 8010 Graz, Austria.
FAU - Modhave, Dattatray
AU  - Modhave D
AD  - Galapagos NV, Mechelen, Belgium.
FAU - Sharma, Sheena
AU  - Sharma S
AD  - Department of Pharmaceutical Sciences, Washington State University, Spokane, WA.
FAU - Balhara, Ankit
AU  - Balhara A
AD  - Department of Pharmaceutics, University of Washington, Seattle, WA.
FAU - Singh, Dilip K
AU  - Singh DK
AD  - Sandoz Development Center, Hyderabad, Telangana, India.
FAU - Ramalingam, Manikandan
AU  - Ramalingam M
AD  - Granules India Limited, Hyderabad, Telangana, India.
FAU - Shah, Ravi
AU  - Shah R
AD  - National Institute of Pharmaceutical Education and Research, Ahmedabad, Gujarat, 
      India.
FAU - Pavankumarraju, Surapuraju
AU  - Pavankumarraju S
AD  - KIVIPHARM CO. LTD., Zhangjiakou, Hebei, China.
FAU - Kurmi, Moolchand
AU  - Kurmi M
AD  - Biocon Bristol Myers Squibb R&D Centre (BBRC), Synegene International Limited, 
      Bangalore 560099, India.
FAU - Mariappan, T Thanga
AU  - Mariappan TT
AD  - Biocon Bristol Myers Squibb R&D Centre (BBRC), Synegene International Limited, 
      Bangalore 560099, India; Bristol Myers Squibb (BMS), Bangalore, India. Electronic 
      address: thanga.mariappan@bms.com.
FAU - Bhutani, Hemant
AU  - Bhutani H
AD  - Novartis Healthcare Private Limited, Hyderabad, Telangana, India. Electronic 
      address: hemant.bhutani@novartis.com.
FAU - Prasad, Bhagwat
AU  - Prasad B
AD  - Department of Pharmaceutical Sciences, Washington State University, Spokane, WA. 
      Electronic address: bhagwat.prasad@wsu.edu.
LA  - eng
PT  - Biography
PT  - Historical Article
PT  - Journal Article
DEP - 20211023
PL  - United States
TA  - J Pharm Sci
JT  - Journal of pharmaceutical sciences
JID - 2985195R
SB  - IM
MH  - *Awards and Prizes
MH  - History, 20th Century
MH  - Humans
MH  - Male
MH  - *Mentors
PS  - Singh S
FPS - Singh, Saranjit
COIS- Declaration of Competing Interest The authors declare that they have no known 
      competing interests that could have appeared to influence the work reported in 
      this paper.
EDAT- 2021/10/27 06:00
MHDA- 2022/04/21 06:00
CRDT- 2021/10/26 20:12
PHST- 2021/10/19 00:00 [received]
PHST- 2021/10/21 00:00 [revised]
PHST- 2021/10/21 00:00 [accepted]
PHST- 2021/10/27 06:00 [pubmed]
PHST- 2022/04/21 06:00 [medline]
PHST- 2021/10/26 20:12 [entrez]
AID - S0022-3549(21)00566-9 [pii]
AID - 10.1016/j.xphs.2021.10.024 [doi]
PST - ppublish
SO  - J Pharm Sci. 2022 May;111(5):1224-1231. doi: 10.1016/j.xphs.2021.10.024. Epub 
      2021 Oct 23.